The crocuses are beginning to bloom! A sign promising the fullness of new growth. (Photo by A. Keith Carreiro, March 2016.)
However, major progress has been made in the following areas listed below:
An ISBN has been picked for the first novella, Immortality Wars: the Penitent – Part One.
An ISBN is explained in a Wikipedia article, in part, as follows below:
The International Standard Book Number (ISBN) is a unique[a][b] numeric commercial book identifier.
An ISBN is assigned to each edition and variation (except reprintings) of a book. For example, an e-book, a paperback and a hardcover edition of the same book would each have a different ISBN. The ISBN is 13 digits long if assigned on or after 1 January 2007, and 10 digits long if assigned before 2007. The method of assigning an ISBN is nation-based and varies from country to country, often depending on how large the publishing industry is within a country.
Some of the quotes that come from other sources, and are listed at the front end of the story, have been changed. These quotes could not be used either because the rightsholder refused permission to do so, or a more extensive time is needed to gain said permission, such that the publication would be delayed.
The dedication has been written.
The copyright section is completed.
The table of contents is formatted.
The basic, overall formatting has been decided.
The acknowledgement page is completed.
The sampler for the next sequel, the Penitent – Part Two, has been selected.
This is a major hurdle for me, and it has become a major challenge as well. However, I have traveled too far down this self–publishing road to be deterred, even stopped, at this critical point. I am confident that I will get passed this critical moment in the story’s journey in getting it before an audience.
I welcome you to write me and let me know about any thoughts or ideas you might have on what I have shared with you here in this blog.
If you enjoyed reading this post, please share it with others.
Disclosure of Material Connection: I have not received any compensation for writing this post. I have no material connection to the brands, products or services that I have mentioned here. I am disclosing this information in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”